TRAPPC6B: A Protein Target for Neurodegenerative Disorders and Cancer

Target Name: TRAPPC6B

NCBI ID: G122553

TRAPPC6B: A Protein Target for Neurodegenerative Disorders and Cancer

TRAPPC6B (Transient receptor potential cation channel subfamily B member 6B) is a protein that is expressed in many different tissues and cells in the body. It is a potential drug target and has been identified as a biomarker for various diseases, including neurodegenerative disorders, cancer , and autoimmune diseases.

TRAPPC6B is a transmembrane protein that is characterized by its ability to regulate the movement of positively charged ions, or ions with a positive charge, into and out of cells. It is a member of the transient receptor potential cation channel subfamily B, which is a family of proteins that are involved in the regulation of ion channels and other signaling pathways.

TRAPPC6B is expressed in many different tissues and cells in the body, including the brain, heart, liver, and muscle. It is also expressed in various types of cancer, including breast, ovarian, and prostate cancer.

One of the key functions of TRAPPC6B is its role in the regulation of ion channels. These channels are responsible for allowing ions to flow into and out of cells, and they are critical for the proper functioning of many different signaling pathways in the body.

TRAPPC6B is also involved in the regulation of cell signaling pathways. It is a signaling molecule that can interact with a variety of different proteins, including those involved in neurodegenerative disorders, cancer, and autoimmune diseases.

TRAPPC6B is a potential drug target because of its involvement in the regulation of ion channels and cell signaling pathways. Many diseases, including neurodegenerative disorders and cancer, are characterized by the disruption of these signaling pathways, and drugs that can restore normal function to these pathways may have a therapeutic effect.

In addition to its potential therapeutic applications, TRAPPC6B is also a valuable biomarker for various diseases. Its expression is often reduced in the brains and other tissues of people with neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. This suggests that these disorders may be caused by disruptions in the signaling pathways that TRAPPC6B is involved in.

Similarly, the expression of TRAPPC6B is often increased in the brains and other tissues of people with cancer, including breast, ovarian, and prostate cancer. This suggests that these cancers may be caused by disruptions in the signaling pathways that TRAPPC6B is involved in.

In addition to its potential therapeutic and biomarker applications, TRAPPC6B is also an interesting structural protein. Its three-dimensional structure has been determined through a variety of techniques, including X-ray crystallography and electron microscopy. This structure provides insight into the mechanisms of TRAPPC6B's function and also provide a structural basis for the development of drugs that target this protein.

Overall, TRAPPC6B is a protein that is involved in the regulation of ion channels and cell signaling pathways. Its potential therapeutic applications and biomarker status make it an attractive target for research into a variety of diseases. Further research is needed to fully understand the mechanisms of TRAPPC6B's function and its potential as a drug and biomarker.

Protein Name: Trafficking Protein Particle Complex Subunit 6B

Functions: Component of a transport protein particle (TRAPP) complex that may function in specific stages of inter-organelle traffic (PubMed:16025134, PubMed:16828797). Specifically involved in the early development of neural circuitry, likely by controlling the frequency and amplitude of intracellular calcium transients implicated in the regulation of neuron differentiation and survival (Probable)

More Common Targets